| 6328 |
Ebara Jitsugyo Co., Ltd.
|
Strategy |
|
Notice on the Revision of numerical targets in the medium-term management plan
|
Aug 5, 2026
NEW
|
| 2138 |
CROOZ GROUP
|
Strategy |
|
[CROOZ GROUP] Announcing New Business Development | August 2026
|
Aug 5, 2026
NEW
|
| 7273 |
Ikuyo Co., Ltd.
|
Strategy |
|
Notice Regarding the Asset Transfer of the EV Bus Business
|
Aug 4, 2026
NEW
|
| 9376 |
Eurasia Travel Services Co., Ltd.
|
Strategy |
|
Structure of this document (Agenda)
|
Aug 4, 2026
NEW
|
| 6522 |
Astlerisk Inc.
|
Strategy |
|
RFID Solution Launch. Next-generation RFID solution ‘AsReader BOX-Type’, Notice of deployment at Coca flagship store
|
Aug 4, 2026
NEW
|
| 4578 |
Otsuka Holdings Corporation
|
Strategy |
|
VOYXACT (Sobeprenlimab) IgA nephropathy treatment phase 3 data release
|
Aug 4, 2026
|
| 9212 |
Green Earth Institute 株式会社
|
Strategy |
|
Transcription of Long-term Vision Briefing for Individual Investors
|
Aug 3, 2026
|
| 3772 |
Wealth Management Co., Ltd.
|
M&A |
|
Notice Regarding the Formation of Real Estate Security Token Offering and Transfer of Real Estate Trust Beneficiary Interest, and Asset Management Agreement
|
Aug 3, 2026
|
| 8439 |
Tokyo Century Corporation
|
Strategy |
|
Notice of Basic Agreement Signing Relating to the Transfer of an Interest in a Consolidated Subsidiary to an Equity-method Affiliate and Recording of Extraordinary Profit
|
Aug 3, 2026
|
| 8001 |
Itochu Corporation
|
M&A |
|
Notice of Basic Agreement on SKY-U equity acquisition through joint investment with Tokyo Century and participation in ACG
|
Aug 3, 2026
|
| 7804 |
B&P Co., Ltd.
|
M&A |
|
The official title of the document is not displayed in the main text
|
Aug 3, 2026
|
| 7564 |
株式会社 ワ ー ク マ ン
|
Strategy |
|
Taiwan Subsidiary Establishment (Specially Designated Subsidiary) Announcement
|
Aug 3, 2026
|
| 4599 |
Stemrim Co., Ltd.
|
Strategy |
|
Patent registration (Development Code: SR-GT1) for stem cell gene therapy technology aimed at curing hereditary epidermolysis bullosa (Korea)
|
Aug 3, 2026
|
| 4591 |
株式会社会リボミック
|
M&A |
|
Domestic Phase 3 Clinical Trial of Omedaptanib Pegol for Achondroplasia: Announcement of Expanded Investigational Sites
|
Aug 3, 2026
|
| 2934 |
Jay Frontier Co., Ltd.
|
M&A |
|
Notice Regarding Comprehensive Business Partnership with Rakuten Group
|
Aug 3, 2026
|
| 3415 |
Tokyo Base Inc.
|
Strategy |
|
[TOKYO BASE] Establishment of Subsidiary in Taiwan and Overseas Expansion Strategy | July 2026
|
Jul 31, 2026
|
| 3269 |
Advance Residence Investment Corporation
|
Strategy |
|
【Advance Residence】Asset Management Contract Conclusion｜July 2026
|
Jul 31, 2026
|
| 7050 |
Frontier International Corporation
|
Strategy |
|
Frontier International Corporation Business Strategy and Progress | July 2026
|
Jul 31, 2026
|
| 6741 |
Japan Signal Co., Ltd.
|
M&A |
|
Notice of Capital and Business Alliance with Nagoya Electric Industry
|
Jul 31, 2026
|
| 4914 |
Takasago Perfumery & Chemical Inc.
|
Strategy |
|
【Takasago Perfumery & Chemical】Ibaraki Land Acquisition | July 2026
|
Jul 31, 2026
|
